NCT03881540

Brief Summary

The aim of this study was to investigate the effectiveness of structured lifestyle intervention following a transcultural diabetes nutrition algorithm (tDNA) care compared to usual diabetes care in patients with overweight, obesity and type 2 diabetes (T2D), receiving either the motivational interviewing counseling or conventional counselling technique in an outpatient clinic setting. The hypothesis is weight loss and glycated haemoglobin (A1C) level will be improved in patients following the tDNA care compared to usual diabetes care and the improvements will be greater in those receiving motivational interviewing counseling than conventional counselling.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P50-P75 for not_applicable diabetes

Timeline
Completed

Started Jun 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

March 12, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 19, 2019

Completed
Last Updated

March 22, 2019

Status Verified

March 1, 2019

Enrollment Period

1.5 years

First QC Date

March 12, 2019

Last Update Submit

March 20, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Weight

    Anthropometry

    6 months, 12 months

  • Change in Glycated haemoglobin (A1C)

    Biochemical measure

    6 months, 12 months

Secondary Outcomes (8)

  • Change in percentage body fat

    6 months

  • Change in fasting blood glucose

    6 months

  • Change in total cholesterol, LDL-C and HDL-C

    6 months

  • Change in High sensitivity C-Reactive Protein (HsCRP)

    6 months

  • Change in systolic and diastolic blood pressure

    6 months

  • +3 more secondary outcomes

Study Arms (3)

tDNA-MI group

ACTIVE COMPARATOR

Follow tDNA intervention and motivational interviewing counselling

Other: tDNA-MI group

tDNA-CC group

ACTIVE COMPARATOR

Follow tDNA intervention and conventional counselling

Other: tDNA-CC group

UC group

OTHER

Follow a conventional diet with standard diabetes support and lifestyle education

Other: UC group

Interventions

tDNA care with structured low calorie meal plan of 1200-1500 kcal/day with conventional foods + 1-2 serving of diabetes specific meal replacements and motivational interviewing counseling. .

tDNA-MI group

tDNA care with structured low calorie meal plan of 1200-1500 kcal/day with conventional foods + 1-2 serving of diabetes specific meal replacements+ 150 min/week of moderate intensity exercise + and conventional counselling.

tDNA-CC group

Meal plan of 1200-1500 kcal/day using conventional foods + 150 min/week of moderate intensity exercise + and conventional counselling

UC group

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with type 2 diabetes mellitus, requiring weight loss
  • Treated with oral hypoglycaemic medications and/or lifestyle modifications
  • Medications have been optimised with no changes in pharmacotherapy in the past three months
  • Aged between 30 to 65 years
  • BMI of \>23 kg/m²
  • A1C between 7% to 9%
  • Failed to achieve HbA1c reduction in the past three months even after seeing a dietitian
  • Willing to comply with study procedures.

You may not qualify if:

  • Patients whom weight loss might not be safe
  • Patients diagnosed with type 1 diabetes mellitus and type 2 diabetes mellitus with basal or multiple insulin injections
  • Patients with weight loss exceeding 5 kg in the past three months
  • Patients with current use of medications/meal replacements for weight loss
  • Patients with cancer requiring treatment for the past five years, except of non-melanoma skin cancers or cancers that have been clearly cured
  • Patients with history of bariatric surgery, small bowel resection, or extensive bowel resection
  • Patients with cardiovascular disease (heart attack or procedure within past three months or participation in cardiac rehabilitation program within last three months, stroke or history/treatment for transient ischaemic attacks in the past three months, or documented history of pulmonary embolus for the past six months)
  • Patients with renal disease with eGFR \<60 ml/min (based on MDRD) or currently receiving dialysis
  • Patients with chronic alcoholism
  • Patients who are currently pregnant or nursing
  • Patients who plan to relocate where it does not permit full participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

International Medical University

Kuala Lumpur, 57000, Malaysia

Location

Related Publications (1)

  • Gilcharan Singh HK, Chee WSS, Hamdy O, Mechanick JI, Lee VKM, Barua A, Mohd Ali SZ, Hussein Z. Eating self-efficacy changes in individuals with type 2 diabetes following a structured lifestyle intervention based on the transcultural Diabetes Nutrition Algorithm (tDNA): A secondary analysis of a randomized controlled trial. PLoS One. 2020 Nov 30;15(11):e0242487. doi: 10.1371/journal.pone.0242487. eCollection 2020.

MeSH Terms

Conditions

Diabetes MellitusObesity

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Winnie SS Chee, PhD

    IMU University, Malaysia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 12, 2019

First Posted

March 19, 2019

Study Start

June 1, 2014

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

March 22, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations